BNIP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.289800E-01
Normal-vs-Stage2
9.572200E-01
Normal-vs-Stage3
8.634800E-01
Normal-vs-Stage4
8.742200E-01
Stage1-vs-Stage2
8.366200E-01
Stage1-vs-Stage3
8.997200E-01
Stage1-vs-Stage4
9.378800E-01
Stage2-vs-Stage3
9.311000E-01
Stage2-vs-Stage4
9.141400E-01
Stage3-vs-Stage4
9.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.062200E-01
Normal-vs-AfricanAmerican
9.893200E-01
Normal-vs-Asian
3.205400E-01
Caucasian-vs-AfricanAmerican
8.597400E-01
Caucasian-vs-Asian
2.822400E-02
AfricanAmerican-vs-Asian
2.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.636600E-01
Normal-vs-Female
8.956400E-01
Male-vs-Female
8.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.197000E-01
Normal-vs-Age(41-60Yrs)
7.479800E-01
Normal-vs-Age(61-80Yrs)
8.882000E-01
Normal-vs-Age(81-100Yrs)
4.584800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.788400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.356200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.185800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.157030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.825700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.866200E-01
Normal-vs-Daily Drinker
8.528800E-01
Normal-vs-Weekly Drinker
7.311400E-01
Normal-vs-Occasional Drinker
7.810200E-01
Normal-vs-Social Drinker
8.774600E-01
Non Drinker-vs-Daily Drinker
4.500800E-01
Non Drinker-vs-Weekly Drinker
9.402600E-01
Non Drinker-vs-Occasional Drinker
2.918600E-01
Non Drinker-vs-Social Drinker
4.300400E-01
Daily Drinker-vs-Weekly Drinker
4.736200E-01
Daily Drinker-vs-Occasional Drinker
9.508600E-01
Daily Drinker-vs-Social Drinker
7.776800E-01
Weekly Drinker-vs-Occasional Drinker
3.307200E-01
Weekly Drinker-vs-Social Drinker
4.824600E-01
Occasional Drinker-vs-Social Drinker
7.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.762000E-01
Normal-vs-Grade 2
4.540300E-03
Normal-vs-Grade 3
1.104570E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.907730E-02
Grade 1-vs-Grade 3
5.659800E-02
Grade 1-vs-Grade 4
9.762000E-01
Grade 2-vs-Grade 3
8.248200E-02
Grade 2-vs-Grade 4
4.540300E-03
Grade 3-vs-Grade 4
1.104570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.002400E-01
Normal-vs-NonDiabetic
9.205800E-01
Diabetic-vs-NonDiabetic
4.534200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.494400E-01
Normal-vs-NoPancreatitis
9.929600E-01
Pancreatitis-vs-NoPancreatitis
1.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.337600E-01
Normal-vs-N1
9.898200E-01
N0-vs-N1
8.308600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.251200E-01
Normal-vs-TP53-NonMutant
7.433000E-01
TP53-Mutant-vs-TP53-NonMutant
1.027670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
